Last 12 months
Inside the activity.
2 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 9 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 2 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 5,586 | $38.59 | $215,555.92 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $37.00-$37.99 - 1,200 shares; $38.00-$38.99 - 3,508 shares; $39.00-$39.99 - 1,878 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC |
Brottem John L.General Counsel
|
Exercise / conversionCommon Stock | 5,586 | $9.48 | $52,955.28 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 1,000 | $38.59 | $38,588.60 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $37.00-$37.99 - 1,200 shares; $38.00-$38.99 - 3,508 shares; $39.00-$39.99 - 1,878 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:56 UTC |
Brottem John L.General Counsel
|
Exercise / conversionCommon Stock | 1,000 | $9.48 | $9,480.00 |
DisclosureSEC source: 0001484612-22-000024 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:27 UTC |
Ahmed NabeelChief Financial Officer
|
SaleCommon Stock | 477 | $41.72 | $19,900.44 |
DisclosureSEC source: 0001484612-22-000022 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,913 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 955 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 424 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| March 09, 2022 Filed Mar 15, 2022 23:54 UTC |
Porter Stacey L.Chief People Officer
|
SaleCommon Stock | 416 | $41.72 | $17,355.52 |
DisclosureSEC source: 0001484612-22-000023 · edgardoc.xml · nonDerivative · entry 1 Porter Stacey L. · CIK 0001889204 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,906 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,193 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 500 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:51 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 1,003 | $43.73 | $43,861.19 |
DisclosureSEC source: 0001484612-22-000020 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,806 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · balance_after: Includes 500 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:47 UTC |
Vazquez MartinChief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001484612-22-000019 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,151 Underlying: Common Stock · 5,000 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests in 48 equal monthly installments beginning on March 3, 2020, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:47 UTC |
Vazquez MartinChief Operating Officer
|
SaleCommon Stock | 5,000 | $43.51 | $217,558.50 |
DisclosureSEC source: 0001484612-22-000019 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,525 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 745 shares; $43.00-$43.99 - 3,355 shares; $44.00 - $44.99 - 900 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:47 UTC |
Vazquez MartinChief Operating Officer
|
Exercise / conversionCommon Stock | 5,000 | $8.62 | $43,100.00 |
DisclosureSEC source: 0001484612-22-000019 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:55 UTC |
Trigg LeslieDirector · Chair and CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000021 · edgardoc.xml · derivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,711 Underlying: Common Stock · 20,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vested in 48 equal monthly installments beginning on October 19, 2017. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:55 UTC |
Trigg LeslieDirector · Chair and CEO
|
SaleCommon Stock | 20,000 | $43.49 | $869,746.00 |
DisclosureSEC source: 0001484612-22-000021 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,613 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 3,394 shares; $43.00-$43.99 - 12,474 shares; $44.00 - $44.99 - 4,132 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 500 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:55 UTC |
Trigg LeslieDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 20,000 | $3.88 | $77,600.00 |
DisclosureSEC source: 0001484612-22-000021 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC |
Brottem John L.General Counsel
|
Exercise / conversionPerformance Options (right to buy) · Derivative | 3,000 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,265 Underlying: Common Stock · 3,000 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC |
Brottem John L.General Counsel
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,002 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,224 Underlying: Common Stock · 7,002 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 7,002 | $35.92 | $251,490.83 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,309 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 7,257 shares; $46.00-$46.99 - 2,745 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC |
Brottem John L.General Counsel
|
Exercise / conversionCommon Stock | 7,002 | $9.48 | $66,378.96 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 3,000 | $35.92 | $107,751.00 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,309 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 7,257 shares; $46.00-$46.99 - 2,745 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:58 UTC |
Brottem John L.General Counsel
|
Exercise / conversionCommon Stock | 3,000 | $9.48 | $28,440.00 |
DisclosureSEC source: 0001484612-22-000018 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 3, 2022 21:09 UTC |
Trigg LeslieDirector · Chief Executive Officer
|
GrantCommon Stock | 11,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000016 · edgardoc.xml · nonDerivative · entry 3 Trigg Leslie · CIK 0001304125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,113 F3 · shares: Represents portion of stock units granted to the reporting person on February 2, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 16:11 UTC |
Vazquez MartinChief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001484612-22-000017 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,151 Underlying: Common Stock · 5,000 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests in 48 equal monthly installments beginning on March 3, 2020, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 16:11 UTC |
Vazquez MartinChief Operating Officer
|
SaleCommon Stock | 5,000 | $37.44 | $187,198.00 |
DisclosureSEC source: 0001484612-22-000017 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,525 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $36.00-$36.99 - 700 shares; $37.00-$37.99 - 4,146 shares; $38.00-$38.99 - 154 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 16:11 UTC |
Vazquez MartinChief Operating Officer
|
Exercise / conversionCommon Stock | 5,000 | $8.62 | $43,100.00 |
DisclosureSEC source: 0001484612-22-000017 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:09 UTC |
Trigg LeslieDirector · Chief Executive Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000016 · edgardoc.xml · derivative · entry 5 Trigg Leslie · CIK 0001304125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,711 Underlying: Common Stock · 20,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vested in 48 equal monthly installments beginning on October 19, 2017. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:09 UTC |
Trigg LeslieDirector · Chief Executive Officer
|
SaleCommon Stock | 20,000 | $37.50 | $750,034.00 |
DisclosureSEC source: 0001484612-22-000016 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,407 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $36.00-$36.99 - 2,250 shares; $37.00-$37.99 - 16,116 shares; $38.00-$38.99 - 1,634 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:09 UTC |
Trigg LeslieDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 20,000 | $3.88 | $77,600.00 |
DisclosureSEC source: 0001484612-22-000016 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:46 UTC |
Brottem John L.General Counsel
|
GrantCommon Stock | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000010 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,309 F2 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:46 UTC |
Brottem John L.General Counsel
|
GrantCommon Stock | 23,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000010 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,990 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 17:01 UTC |
Vazquez MartinChief Operating Officer
|
GrantCommon Stock | 2,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000014 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,525 F2 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 17:01 UTC |
Vazquez MartinChief Operating Officer
|
GrantCommon Stock | 39,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000014 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,327 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 22:06 UTC |
Williamson Steven S.Chief Commercial Officer
|
GrantCommon Stock | 1,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000015 · edgardoc.xml · nonDerivative · entry 2 Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,745 F2 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 22:06 UTC |
Williamson Steven S.Chief Commercial Officer
|
GrantCommon Stock | 27,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000015 · edgardoc.xml · nonDerivative · entry 1 Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,207 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:56 UTC |
Ahmed NabeelChief Financial Officer
|
GrantCommon Stock | 1,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000013 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,966 F3 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:56 UTC |
Ahmed NabeelChief Financial Officer
|
GrantCommon Stock | 27,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000013 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,428 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. F2 · balance_after: Includes 489 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2021 to August 31, 2021. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:54 UTC |
Porter Stacey L.Chief People Officer
|
GrantCommon Stock | 934 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000012 · edgardoc.xml · nonDerivative · entry 2 Porter Stacey L. · CIK 0001889204 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,822 F2 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:54 UTC |
Porter Stacey L.Chief People Officer
|
GrantCommon Stock | 16,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000012 · edgardoc.xml · nonDerivative · entry 1 Porter Stacey L. · CIK 0001889204 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,888 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:47 UTC |
Racine Jean-OlivierChief Technology Officer
|
GrantCommon Stock | 1,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000011 · edgardoc.xml · nonDerivative · entry 2 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,577 F2 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:47 UTC |
Racine Jean-OlivierChief Technology Officer
|
GrantCommon Stock | 21,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000011 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,368 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:44 UTC |
Trigg LeslieDirector · Chief Executive Officer
|
GrantCommon Stock | 48,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000009 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,407 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 25, 2022 Filed Jan 25, 2022 23:14 UTC |
Williamson Steven S.Chief Commercial Officer
|
SaleCommon Stock | 2,280 | $37.74 | $86,047.20 |
DisclosureSEC source: 0001484612-22-000008 · edgardoc.xml · nonDerivative · entry 2 Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,857 F2 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs described above in footnote (1). This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2022 Filed Jan 25, 2022 23:14 UTC |
Williamson Steven S.Chief Commercial Officer
|
GrantCommon Stock | 9,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000008 · edgardoc.xml · nonDerivative · entry 1 Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,137 F1 · shares: Represents the number shares of Common Stock of the Issuer that vested in connection with performance stock units (PSUs) granted to the reporting person on March 15, 2021 upon confirmation by the Issuer's Compensation Committee of the Board of Directors on January 21, 2022 that the applicable performance criteria for calendar year 2021 had been met. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC |
Brottem John L.General Counsel
|
Exercise / conversionPerformance Options (right to buy) · Derivative | 3,000 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · derivative · entry 6 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,265 Underlying: Common Stock · 3,000 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC |
Brottem John L.General Counsel
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,002 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,226 Underlying: Common Stock · 7,002 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 7,002 | $35.61 | $249,308.31 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,547 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $34.00-$34.99 - 536 shares; $35.00-$35.99 - 5,814 shares; $36.00-$36.99 - 3,652 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC |
Brottem John L.General Counsel
|
Exercise / conversionCommon Stock | 7,002 | $9.48 | $66,378.96 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 3,000 | $35.61 | $106,815.90 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,547 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $34.00-$34.99 - 536 shares; $35.00-$35.99 - 5,814 shares; $36.00-$36.99 - 3,652 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 01:52 UTC |
Brottem John L.General Counsel
|
Exercise / conversionCommon Stock | 3,000 | $9.48 | $28,440.00 |
DisclosureSEC source: 0001484612-22-000007 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:27 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 2,500 | $47.05 | $117,625.00 |
DisclosureSEC source: 0001484612-22-000002 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,547 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 250 shares; $46.00-$46.99 - 331 shares; $47.00-$47.99 - 1,819 shares; $48.00 - $48.99 - 100 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:29 UTC |
Trigg LeslieDirector · Chief Executive Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000004 · edgardoc.xml · derivative · entry 10 Trigg Leslie · CIK 0001304125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,711 Underlying: Common Stock · 10,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vested in 48 equal monthly installments beginning on October 19, 2017. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:29 UTC |
Trigg LeslieDirector · Chief Executive Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000004 · edgardoc.xml · derivative · entry 9 Trigg Leslie · CIK 0001304125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,711 Underlying: Common Stock · 12,500 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vested in 48 equal monthly installments beginning on October 19, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.